Valuation TAUNS Laboratories,Inc.
Stocks
197A
JP3452250008
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 482.00 JPY | +1.90% |
|
+0.21% | -5.30% |
| 07-15 | Callisto Inc. announced that it expects to receive funding from TAUNS Laboratories,Inc. | CI |
| 07-15 | Provigate, Inc. announced that it expects to receive funding from TAUNS Laboratories,Inc. | CI |
Company Valuation: TAUNS Laboratories,Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Market Cap 1 | 41,000 | 51,425 | 51,425 | - |
| Change | - | 25.43% | 0% | - |
| Enterprise Value (EV) 1 | 41,114 | 60,244 | 59,419 | 60,180 |
| Change | - | 46.53% | 2% | 1.28% |
| P/E | 7.1x | 8.67x | 9.69x | 14.3x |
| PBR | 3x | 3.15x | 2.61x | 2.53x |
| PEG | - | 1.16x | -0.4x | -0.4x |
| Capitalization / Revenue | 2.22x | 2.96x | 3.49x | 2.67x |
| EV / Revenue | 2.23x | 3.23x | 4.03x | 3.13x |
| EV / EBITDA | 4.72x | 6.71x | 11.8x | 9.21x |
| EV / EBIT | 5.12x | 7.29x | 15.5x | 12.5x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | 21.75 | 28 | 35.28 | 28 |
| Rate of return | 5.3% | 5.2% | 7.32% | 5.81% |
| EPS 2 | 57.74 | 62.07 | 49.72 | 33.75 |
| Distribution rate | 37.7% | 45.1% | 71% | 83% |
| Net sales 1 | 18,435 | 18,628 | 14,756 | 19,252 |
| EBITDA 1 | 8,706 | 8,980 | 5,053 | 6,531 |
| EBIT 1 | 8,030 | 8,265 | 3,846 | 4,833 |
| Net income 1 | 5,774 | 6,315 | 5,201 | 3,593 |
| Net Debt 1 | 114.1 | 5,157 | 7,994 | 8,755 |
| Reference price 2 | 410.00 | 482.00 | 482.00 | 482.00 |
| Nbr of stocks (in thousands) | 100,000 | 106,692 | 106,692 | - |
| Announcement Date | 13/08/24 | 13/08/25 | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 7.4x | 3.01x | 5.82x | 5.75% | 308M | |
| -49.55x | 14.95x | -109.43x | -.--% | 19.04B | |
| 18.02x | 2.05x | 8.56x | 1.43% | 10.07B | |
| 23.19x | 4.36x | 12.34x | - | 6.68B | |
| -58x | 8.95x | -76.17x | -.--% | 5.97B | |
| 20.48x | 7.04x | 15.91x | 2.81% | 5.53B | |
| 158.64x | 3.94x | 25.83x | -.--% | 4.41B | |
| 20.38x | 3.6x | 11.17x | 1.86% | 4.26B | |
| 16.02x | - | - | 4% | 2.69B | |
| Average | 17.40x | 5.99x | -13.25x | 1.98% | 6.55B | |
| Weighted average by Cap. | -0.15x | 8.18x | -37.65x | 0.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 197A Stock
- Valuation TAUNS Laboratories,Inc.
Select your edition
All financial news and data tailored to specific country editions
